259 related articles for article (PubMed ID: 27631004)
1. Differences in Rhodococcus equi Infections Based on Immune Status and Antibiotic Susceptibility of Clinical Isolates in a Case Series of 12 Patients and Cases in the Literature.
Gundelly P; Suzuki Y; Ribes JA; Thornton A
Biomed Res Int; 2016; 2016():2737295. PubMed ID: 27631004
[TBL] [Abstract][Full Text] [Related]
2. Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.
Huber L; Giguère S; Slovis NM; Carter CN; Barr BS; Cohen ND; Elam J; Erol E; Locke SJ; Phillips ED; Smith JL
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373803
[TBL] [Abstract][Full Text] [Related]
3. Rhodococcus equi infection in HIV-infected individuals: case reports and review of the literature.
Topino S; Galati V; Grilli E; Petrosillo N
AIDS Patient Care STDS; 2010 Apr; 24(4):211-22. PubMed ID: 20377432
[TBL] [Abstract][Full Text] [Related]
4. Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi.
Giguère S; Lee E; Williams E; Cohen ND; Chaffin MK; Halbert N; Martens RJ; Franklin RP; Clark CC; Slovis NM
J Am Vet Med Assoc; 2010 Jul; 237(1):74-81. PubMed ID: 20590498
[TBL] [Abstract][Full Text] [Related]
5. [Long term survival after Rhodococcus equi pneumonia in a patient with human immunodeficiency virus infection in the era of highly active antiretroviral therapy: case report and review].
Vladusić I; Krajinović V; Begovac J
Acta Med Croatica; 2006 Jun; 60(3):259-63. PubMed ID: 16933840
[TBL] [Abstract][Full Text] [Related]
6. Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
Berghaus LJ; Giguère S; Guldbech K
Vet Microbiol; 2013 Oct; 166(3-4):670-5. PubMed ID: 23915992
[TBL] [Abstract][Full Text] [Related]
7. Pyogenic liver abscess due to Rhodococcus equi in an immunocompetent host.
Napoleão F; Damasco PV; Camello TC; do Vale MD; de Andrade AF; Hirata R; de Mattos-Guaraldi AL
J Clin Microbiol; 2005 Feb; 43(2):1002-4. PubMed ID: 15695730
[TBL] [Abstract][Full Text] [Related]
8. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens.
McNeil MM; Brown JM
Eur J Epidemiol; 1992 May; 8(3):437-43. PubMed ID: 1397208
[TBL] [Abstract][Full Text] [Related]
9. Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Mascellino MT; Iona E; Ponzo R; Mastroianni CM; Delia S
Int J Clin Pharmacol Res; 1994; 14(5-6):157-63. PubMed ID: 7672872
[TBL] [Abstract][Full Text] [Related]
10. Rhodococcus equi infections in immunocompetent hosts: case report and review.
Kedlaya I; Ing MB; Wong SS
Clin Infect Dis; 2001 Feb; 32(3):E39-46. PubMed ID: 11170969
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Rhodococcus equi infection with fatal outcome in an immunocompetent patient.
Gabriels P; Joosen H; Put E; Verhaegen J; Magerman K; Cartuyvels R
Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):46-8. PubMed ID: 16424975
[TBL] [Abstract][Full Text] [Related]
12. Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases.
Arlotti M; Zoboli G; Moscatelli GL; Magnani G; Maserati R; Borghi V; Andreoni M; Libanore M; Bonazzi L; Piscina A; Ciammarughi R
Scand J Infect Dis; 1996; 28(5):463-7. PubMed ID: 8953675
[TBL] [Abstract][Full Text] [Related]
13. Effect of Macrolide and Rifampin Resistance on Fitness of
Willingham-Lane JM; Berghaus LJ; Berghaus RD; Hart KA; Giguère S
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331959
[TBL] [Abstract][Full Text] [Related]
14. In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi.
Giguère S; Lee EA; Guldbech KM; Berghaus LJ
Vet Microbiol; 2012 Nov; 160(1-2):207-13. PubMed ID: 22704561
[TBL] [Abstract][Full Text] [Related]
15.
Ranganath N; Mendoza MA; Stevens R; Kind D; Wengenack N; Shah A
J Clin Microbiol; 2024 Mar; 62(3):e0153723. PubMed ID: 38349145
[No Abstract] [Full Text] [Related]
16. Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
Boyen F; Pasmans F; Haesebrouck F
Vet Rec; 2011 Jan; 168(4):101a. PubMed ID: 21257598
[No Abstract] [Full Text] [Related]
17. Invasive infection with Rhodococcus equi--two case reports and review of literature.
Guyssens V; Vandekerckhove L; Colle I; De Rudder P; Blots S; Vogelaers D
Acta Clin Belg; 2010; 65(4):271-5. PubMed ID: 20954468
[TBL] [Abstract][Full Text] [Related]
18. Rhodococcus equi infections of humans. 12 cases and a review of the literature.
Verville TD; Huycke MM; Greenfield RA; Fine DP; Kuhls TL; Slater LN
Medicine (Baltimore); 1994 May; 73(3):119-32. PubMed ID: 8190035
[TBL] [Abstract][Full Text] [Related]
19. Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice.
Burton AJ; Giguère S; Berghaus LJ; Hondalus MK
Antimicrob Agents Chemother; 2015; 59(6):3633-6. PubMed ID: 25824218
[TBL] [Abstract][Full Text] [Related]
20. Persistent Rhodococcus equi infection in a renal transplant patient: case report and review of the literature.
Menon V; Gottlieb T; Gallagher M; Cheong EL
Transpl Infect Dis; 2012 Dec; 14(6):E126-33. PubMed ID: 23013470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
